(E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one
C31H24N2O2 — CID 155516647
Data last refreshed: (MolForge compound catalog, from PubChem)
About (E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one
(E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one (PubChem CID 155516647) has the molecular formula C31H24N2O2 and a molecular weight of 456.55 g/mol. Its IUPAC name is (E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one.
Molecular Properties
| Compound Name | (E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one |
|---|---|
| PubChem CID | 155516647 |
| Molecular Formula | C31H24N2O2 |
| Molecular Weight | 456.55 g/mol |
| Exact Mass | 456.18 |
| IUPAC Name | (E)-1-phenyl-3-[1-phenyl-3-(4-phenylmethoxyphenyl)pyrazol-4-yl]prop-2-en-1-one |
| SMILES | O=C(/C=C/c1cn(-c2ccccc2)nc1-c1ccc(OCc2ccccc2)cc1)c1ccccc1 |
| InChI | InChI=1S/C31H24N2O2/c34-30(25-12-6-2-7-13-25)21-18-27-22-33(28-14-8-3-9-15-28)32-31(27)26-16-19-29(20-17-26)35-23-24-10-4-1-5-11-24/h1-22H,23H2/b21-18+ |
| InChIKey | KQZIDOFFYMUKKF-DYTRJAOYSA-N |
| XLogP | 7.01 |
| TPSA | 44.12 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 456.55 |
| LogP ≤ 5 | 7.01 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155516647 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.